Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme (Q43113040)

14 November 2017

title

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme (English)

1 reference

14 November 2017

1 reference

12

1 reference

14 November 2017

Christopher B. Granger

6

object named as

Christopher B Granger

1 reference

14 November 2017

5

Karl Swedberg

1 reference

14 November 2017

7

Salim Yusuf

1 reference

14 November 2017

13

John J V McMurray

1 reference

14 November 2017

3

Mark C Petrie

1 reference

14 November 2017

4

Marc A Pfeffer

1 reference

CHARM Investigators and Committees

14 November 2017

14

object named as

CHARM Investigators and Committees

1 reference

14 November 2017

10

Eric L Michelson

1 reference

14 November 2017

2

Duolao Wang

1 reference

14 November 2017

Nathaniel M Hawkins

1

1 reference

14 November 2017

Scott D Solomon

8

1 reference

14 November 2017

Jan Ostergren

9

1 reference

14 November 2017

Stuart J Pocock

11

1 reference

14 November 2017

publication date

31 March 2010

1 reference

European Journal of Heart Failure

14 November 2017

published in

1 reference

14 November 2017

volume

12

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

557-565

1 reference

Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Cardiovascular events associated with ipratropium bromide in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ040

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ040

1 reference

14 November 2017

1 reference